In addition, recurrent gene–gene fusion events (20–30% in T-ALL) lead to overexpression of wild type proteins (e.g. STIL::TAL) [7] or fusion proteins with aberrant protein functions (e.g. NUP214::ABL1) [8]. The gene discussed is STIL; the disease is acute lymphoblastic leukemia.